Ijeabuonwu AmalaChukwu M, Bernatoniene Jurga, Pranskuniene Zivile
Department of Drug Technology and Social Pharmacy, Lithuanian University of Health Sciences, LT-50162 Kaunas, Lithuania.
Institute of Pharmaceutical Technologies, Lithuanian University of Health Sciences, LT-50162 Kaunas, Lithuania.
Plants (Basel). 2024 Oct 9;13(19):2821. doi: 10.3390/plants13192821.
Skin diseases in Norway represents an important area of study due to their incidence and prevalence, yet ethnobotanical research in this context remains scarce. The aim of this study was to evaluate the knowledge of Norwegian traditional medicine regarding the treatment of skin diseases and cosmetic purposes through a comparative analysis with EMA monographs. Participants were surveyed using semi-structured interviews. The two samples comprised 22 individuals from Bodø and 26 individuals from other Norwegian communities, all of whom use medicinal plants for the treatment of skin diseases and cosmetic purposes. The indications for skin diseases identified in the study were compared with the European Union herbal monographs published by the European Medicines Agency. Fieldwork was conducted between June 2022 and September 2023, during which 42 plant species from 22 families were recorded. More than half of these plant species (65.38%) were used without European Medicines Agency-approved medical indications. From a public safety perspective, ensuring the safety of self-treatment for skin diseases is a critical research focus for future ethnobotanical studies.
由于皮肤病的发病率和患病率，挪威的皮肤病是一个重要的研究领域，但在这方面的民族植物学研究仍然很少。本研究的目的是通过与欧洲药品管理局（EMA）专论进行比较分析，评估挪威传统医学在皮肤病治疗和美容方面的知识。采用半结构化访谈对参与者进行调查。两个样本包括来自博德的22人和来自挪威其他社区的26人，他们都使用药用植物治疗皮肤病和用于美容目的。将研究中确定的皮肤病适应症与欧洲药品管理局发布的欧盟草药专论进行了比较。实地调查于2022年6月至2023年9月期间进行，在此期间记录了来自22个科的42种植物。这些植物物种中有一半以上（65.38%）在没有欧洲药品管理局批准的医学适应症的情况下被使用。从公共安全的角度来看，确保皮肤病自我治疗的安全性是未来民族植物学研究的一个关键重点。
